Aehr Test Systems (AEHR) designs and manufactures wafer-level and package-level test and burn-in systems used to qualify semiconductors — a niche that has become increasingly relevant as AI accelerators, silicon photonics, and power devices require exhaustive reliability screening. The Fremont, California-based company, which employs roughly 140 people, sells its FOX and Sonoma platforms to chipmakers, outsourced assembly partners, and hyperscale customers.
In Friday's session, the stock traded at $44.33, down $3.61 or 7.53% from Thursday's close of $47.94. The direction of the move was clearly negative, and no verified company-specific catalyst was found to explain it. The decline reflects continued de-risking across small-cap AI hardware suppliers rather than a new fundamental disclosure.
The dominant driver was sector sympathy. Semiconductor test and burn-in equipment is one of the most cyclical, order-driven corners of the chip supply chain, and its small-cap constituents are being sold in tandem as investors trim exposure to AI hardware names with high revenue multiples. Peer pressure was visible across unrelated technologies: photonics, 800-volt power delivery, and burn-in testing businesses all traded lower, treated as a single basket of speculative AI-adjacent suppliers despite very different end markets.
AEHR's Nov. 3 reaction is the backdrop. Record quarterly revenue of $33.01 million — a 200% year-over-year increase — plus GAAP net income of $7.18 million and a raised fiscal 2027 revenue outlook of $150 million drove shares from $51.47 to $65.11 in a single session. That rally did not hold. Jefferies trimmed its target to $140 from $175 and Lake Street cut its to $90 from $110, both maintaining Buy ratings, while the semi-cap equipment complex saw broader multiple compression. The market has since been repricing the quarter's good news rather than disputing it.
Turnover has been running near or below the stock's recent average pace, with sessions of roughly 1.0 million to 1.5 million shares changing hands compared with a typical 2.2 million to 2.5 million, suggesting a lack of aggressive new buyers rather than heavy institutional liquidation. Liquidity is thin for a company with a market capitalization of roughly $1.45 billion, and that thinness amplifies percentage moves. The stock sits well beneath its 20-day and 60-day moving averages and below its 200-day average near $74, having broken several support levels on the way down. Broader semiconductor indices were mixed, but small-cap equipment and test names underperformed the large-cap leaders — a divergence consistent with rotation out of higher-beta suppliers.
On a scale where 0 means no meaningful news and a price move that is entirely normal for the stock, and 100 means transformative news paired with an extreme, rare move, AEHR scores 11 out of 100. No company-specific disclosure, filing, or analyst action accompanied this session, and the identifiable drivers were sector-level, making them weak relative to a company that raised guidance only two weeks ago.
The price behavior was unremarkable as well. The decline was about 1.3 times the stock's typical absolute daily move of roughly 5.8%, and moves of similar or greater magnitude occurred 15 times in the last 60 sessions. Weak news and a routine-for-this-stock swing combine into a low score.
The next quarterly report, covering the December quarter, is expected in mid-January. Investors will focus on whether the $109.3 million effective backlog converts into revenue on schedule and whether gross margin holds near the 47.5% reported last quarter. The most consequential near-term milestone is customer-side: a fully configured FOX-XP wafer-level burn-in cell is scheduled for installation at a Taiwan-based assembly partner in early calendar 2027, with a decision on broader high-volume deployment expected within several months of validation. Sonoma shipments to a hyperscale customer's second AI processor ramp during 2027. Analyst consensus remains a Strong Buy with an average target near $117. Key risks include severe customer concentration, an order book that can shift quarter to quarter, a valuation still near 30 times sales, and persistent insider selling.
Tickeron operates hundreds of AI trading bots covering thousands of tickers, but only the strongest performers under current market conditions are elevated into its curated Trending AI Robots section. The bots differ widely by strategy, holding timeframe, performance metrics, and the symbols they trade, so the featured roster shifts as market conditions change. For readers tracking volatile, high-beta names like this one, that page offers a practical way to see which automated strategies are currently working and how they are positioned.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
The 50-day moving average for AEHR moved below the 200-day moving average on November 18, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AEHR as a result. In 73 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 86%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AEHR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
The Aroon Indicator for AEHR entered a downward trend on November 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where AEHR's RSI Oscillator exited the oversold zone, 26 of 31 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 84%.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
The Moving Average Convergence Divergence (MACD) for AEHR just turned positive on November 03, 2026. Looking at past instances where AEHR's MACD turned positive, the stock continued to rise in 33 of 38 cases over the following month. The odds of a continued upward trend are 87%.
Following a +21.66% 3-day Advance, the price is estimated to grow further. Considering data from situations where AEHR advanced for three days, in 243 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 89%.
The Tickeron Valuation Rating of 4 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.970) is normal, around the industry mean (5.670). AEHR has a moderately low P/E Ratio (-232.913) as compared to the industry average of (68.795). Projected Growth (PEG Ratio) (0.927) is also within normal values, averaging (0.801). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (51.813) is also within normal values, averaging (27.897).
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. AEHR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 77 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AEHR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock better than average.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a manufacturer of burn-in and test equipment for semiconductor manufacturing
Industry ElectronicProductionEquipment